CSF-1 and Ang-2 serum levels — prognostic and diagnostic partners in non-small cell lung cancer

BACKGROUND: Lung cancer is the most incident and lethal form of cancer, with late diagnosis as a major determinant of its bad prognosis. Immunotherapies targeting immune checkpoints improve survival, but positive results encompass only 30%–40% of the patients, possibly due to alternative pathways to...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Ana Luísa, Gomes, Mónica Patrícia, Catarino, Raquel Jorge, Rolfo, Christian, Medeiros, Rui Manuel, Araújo, António Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069916/
https://www.ncbi.nlm.nih.gov/pubmed/30094067
http://dx.doi.org/10.1136/esmoopen-2018-000349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069916/
https://www.ncbi.nlm.nih.gov/pubmed/30094067
http://dx.doi.org/10.1136/esmoopen-2018-000349

Ejemplares similares